| Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies KE Wright, KA Hjerrild, J Bartlett, AD Douglas, J Jin, RE Brown, ... Nature 515 (7527), 427-430, 2014 | 212 | 2014 |
| Bacterial superglue enables easy development of efficient virus-like particle based vaccines S Thrane, CM Janitzek, S Matondo, M Resende, T Gustavsson, ... Journal of nanobiotechnology 14, 1-16, 2016 | 211 | 2016 |
| First-in-human, randomized, double-blind clinical trial of differentially adjuvanted PAMVAC, a vaccine candidate to prevent pregnancy-associated malaria B Mordmüller, M Sulyok, D Egger-Adam, M Resende, WA de Jongh, ... Clinical Infectious Diseases 69 (9), 1509-1516, 2019 | 131 | 2019 |
| Human antibodies that slow erythrocyte invasion potentiate malaria-neutralizing antibodies DGW Alanine, D Quinkert, R Kumarasingha, S Mehmood, FR Donnellan, ... Cell 178 (1), 216-228. e21, 2019 | 126 | 2019 |
| Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination AM Minassian, SE Silk, JR Barrett, CM Nielsen, K Miura, A Diouf, C Loos, ... Med 2 (6), 701-719. e19, 2021 | 111 | 2021 |
| Virus-like particle display of HER2 induces potent anti-cancer responses A Palladini, S Thrane, CM Janitzek, J Pihl, SB Clemmensen, ... Oncoimmunology 7 (3), e1408749, 2018 | 103 | 2018 |
| Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies RO Payne, SE Silk, SC Elias, KH Milne, TA Rawlinson, D Llewellyn, ... JCI insight 2 (12), 2017 | 102 | 2017 |
| Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity C Fougeroux, L Goksøyr, M Idorn, V Soroka, SK Myeni, R Dagil, ... Nature Communications 12 (1), 324, 2021 | 93 | 2021 |
| Structure of Plasmodium falciparum Rh5–CyRPA–Ripr invasion complex W Wong, R Huang, S Menant, C Hong, JJ Sandow, RW Birkinshaw, ... Nature 565 (7737), 118-121, 2019 | 87 | 2019 |
| Enhanced citrate production through gene insertion in Aspergillus niger WA De Jongh, J Nielsen Metabolic engineering 10 (2), 87-96, 2008 | 87 | 2008 |
| Accelerating the clinical development of protein-based vaccines for malaria by efficient purification using a four amino acid C-terminal ‘C-tag’ J Jin, KA Hjerrild, SE Silk, RE Brown, GM Labbé, JM Marshall, KE Wright, ... International journal for parasitology 47 (7), 435-446, 2017 | 68 | 2017 |
| Production of full-length soluble Plasmodium falciparum RH5 protein vaccine using a Drosophila melanogaster Schneider 2 stable cell line system KA Hjerrild, J Jin, KE Wright, RE Brown, JM Marshall, GM Labbé, SE Silk, ... Scientific reports 6 (1), 30357, 2016 | 68 | 2016 |
| The roles of galactitol, galactose‐1‐phosphate, and phosphoglucomutase in galactose‐induced toxicity in Saccharomyces cerevisiae WA de Jongh, C Bro, S Ostergaard, B Regenberg, L Olsson, J Nielsen Biotechnology and bioengineering 101 (2), 317-326, 2008 | 65 | 2008 |
| Vacuum pyrolysis of intruder plant biomasses WA De Jongh, M Carrier, JHH Knoetze Journal of Analytical and Applied Pyrolysis 92 (1), 184-193, 2011 | 62 | 2011 |
| Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells J Jin, RD Tarrant, EJ Bolam, P Angell-Manning, M Soegaard, ... npj Vaccines 3 (1), 32, 2018 | 57 | 2018 |
| The influence of sub-unit composition and expression system on the functional antibody response in the development of a VAR2CSA based Plasmodium falciparum placental malaria … MA Nielsen, M Resende, WA de Jongh, SB Ditlev, B Mordmüller, ... PLoS One 10 (9), e0135406, 2015 | 52 | 2015 |
| Neutralising antibodies block the function of Rh5/Ripr/CyRPA complex during invasion of Plasmodium falciparum into human erythrocytes J Healer, W Wong, JK Thompson, W He, RW Birkinshaw, K Miura, ... Cellular microbiology 21 (7), e13030, 2019 | 45 | 2019 |
| Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody F Lennartz, F Brod, R Dabbs, K Miura, D Mekhaiel, A Marini, MM Jore, ... Nature communications 9 (1), 3822, 2018 | 40 | 2018 |
| The use of Drosophila S2 cells in R&D and bioprocessing W Adriaan de Jongh, S Salgueiro, C Dyring Pharmaceutical Bioprocessing 1 (2), 197-213, 2013 | 31 | 2013 |
| Two-component nanoparticle vaccine displaying glycosylated spike S1 domain induces neutralizing antibody response against SARS-CoV-2 variants L van Oosten, JJ Altenburg, C Fougeroux, C Geertsema, F van den End, ... MBio 12 (5), 10.1128/mbio. 01813-21, 2021 | 30 | 2021 |
Morten Agertoug NielsenAssociate Professor在 sund.ku.dk 的电子邮件经过验证
